Gearing up for the AACC Conference and Expo:

CHICAGO - June 30, 2014 - PRLog -- BBI Solutions, Cardiff, UK, 30/06/15: With AACC fast approaching BBI Solutions are busy preparing for one of the largest annual gatherings of clinical professionals across the globe. This year BBI will be demonstrating how their core values of innovation, partnership quality and results are shaping the future of the business, while keeping pace with market demands.

Through innovative new technology, BBI will be asking customers ‘how optimised is your assay to meet next generation demand? ’ As part of their lateral flow development service, BBI are building a portfolio of novel enhancement technologies and techniques to achieve next generation performance.

BBI will also be inviting attendees to discuss their strategies for penetrating the emerging markets, specifically focusing on emerging territories such as BRIC (Brazil, Russia, India, China) markets. Using a combination of responsible supply chain, automation and low cost manufacturing solutions, BBI will demonstrate how it can support customers in achieving targeted growth within these expanding regions.

Along with these strategic developments, BBI will also be showcasing a number of new raw materials now available off the shelf. These include recombinant Cystatin C antigen and synthetic Rubella IgM serum, the latter an alternative to rare native disease state plasma providing supply security and proven performance across multiple platforms.

A team of BBI Solutions scientists and account managers will be on hand at AACC to discuss BBI’s new products and services. The team looks forward to welcoming attendees to booth #2640 and is offering an appointment booking service at its website, so visitors can make the most of their time at this important event.